Methoxetamine (MXE)

Methoxetamine (MXE) is a dissociative compound belonging to the arylcyclohexylamine class, similar in structure to ketamine and phencyclidine (PCP). It was developed as a research chemical and gained attention in scientific communities for its effects on the N-methyl-D-aspartate (NMDA) receptor, where it acts as an antagonist.

Key Features of Methoxetamine (MXE):

1. NMDA Receptor Interaction: MXE is known for its ability to block NMDA receptors in the brain, which contributes to its dissociative effects.
2. Chemical Structure: MXE features a methoxy group and an ethyl group on its arylcyclohexylamine backbone, distinguishing it from related compounds like ketamine.
3. Pharmacological Studies: MXE has been studied for its potential applications in understanding dissociation, receptor mechanisms, and anesthetic properties.

Research and Use:

Methoxetamine was initially explored as a research chemical for its structural novelty and effects on the central nervous system. Its dissociative properties make it a compound of interest in studying neuropharmacology and receptor dynamics.

Important Information:

Methoxetamine (MXE) is not approved for human or veterinary use. It is intended solely for laboratory research purposes, and its synthesis, sale, and use may be regulated or prohibited in certain jurisdictions.